Obstructive lung diseases and beta-blockers: Where do we stand?

Eur J Intern Med. 2016 Oct;34:e32-e33. doi: 10.1016/j.ejim.2016.04.024. Epub 2016 May 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Asthma / drug therapy
  • Atrial Fibrillation / drug therapy
  • Coronary Artery Disease / drug therapy
  • Heart Failure / drug therapy
  • Humans
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Randomized Controlled Trials as Topic

Substances

  • Adrenergic beta-Antagonists